fig1
![Clinical application of cardiac scintigraphy with bone tracers: controversies and pitfalls in cardiac amyloidosis](https://image.oaes.cc/14e4596d-83fc-421f-ac7d-a7f275c4166d/4521.fig.1.jpg)
Figure 1. Technetium-99m 3,3-diphosphono-1,2-propanodicarboxylic acid bone scan shows a carrier patient with Ala36Pro, visual score 3 with spleen uptake in 2014. After five years, the patient developed cardiac amyloidosis (hATTR CA).
Figure 1. Technetium-99m 3,3-diphosphono-1,2-propanodicarboxylic acid bone scan shows a carrier patient with Ala36Pro, visual score 3 with spleen uptake in 2014. After five years, the patient developed cardiac amyloidosis (hATTR CA).
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/